Moran Kevin Patrick sold VNDA
March 2, 2026 · Form 4 insider transaction
Moran Kevin Patrick sold 42,442 shares of Vanda Pharmaceuticals Inc. at $8.27 per share, a transaction worth $350.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to the withholding tax provisions of the RSU agreements.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.085 to $8.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.